View Older Stories View More Recent Stories

Mar 23, 2017 07:48AM Maxim Group Reiterates Buy Rating and $10 PT on Adamis Pharmaceuticals (ADMP); 'Adamis Could Shine as EpiPen Falters'
Mar 20, 2017 05:31PM Maxim Group Starts Dave & Buster's (PLAY) at Buy
Mar 20, 2017 11:54AM Maxim Maintains Buy Rating and $10 PT on Cytosorbents (CTSO) Following Positive CytoSorb Cases to Treat HLH & CRS Relavance in Cancer Immunotherapy
Mar 17, 2017 08:30AM Nephros Announces $1.2 Million Private Placement
Mar 17, 2017 07:54AM Omeros Corp. (OMER) PT Raised to $22 at Maxim Group Following Strong 4Q Result; 'Omidria Gains Traction'
Mar 17, 2017 07:51AM Maxim Group Reiterates Buy Rating and $5 PT on Oncosec Medical (ONCS); 'Phase 2b of IL-12 Coming in 1h17'
Mar 16, 2017 11:16AM Maxim Group Reiterates Buy Rating and $110 PT on Cytosorbents (CTSO) Following Dr. Reddy Partnership
Mar 16, 2017 09:38AM Trovagene (TROV) Down 20% Following Q4 EPS Miss, Multiple Downgrades
Mar 16, 2017 07:42AM AEterna Zentaris (AEZS) PT Raised to $11 at Maxim Group; 'Zoptrex & Macrilen Could be Transformative'
Mar 16, 2017 07:31AM Maxim Group Downgrades TrovaGene (TROV) to Hold
Mar 16, 2017 07:28AM Maxim Group Upgrades Inovio Pharmaceuticals (INO) to Buy
Mar 15, 2017 08:08AM Maxim Group Reiterates Buy Rating and $14 PT on Mesoblast (MESO) Following Positive Data on Phase 2 Mesenchymal Precursor Cells Trial
Mar 14, 2017 09:37AM Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
Mar 13, 2017 11:02AM Maxim Group Reiterates Buy Rating and $32 PT on Zynerba Pharma (ZYNE) Following Complete Enrollment for Phase2 ZYN002
Mar 13, 2017 07:55AM Bavarian Nordic (BAVA) PT Raised to $53 at Maxim Group on Combination Study of CV-201 & Tecentriq with Roche
Mar 10, 2017 07:24AM BioLife Solutions (BLFS) PT Raised to $4 at Maxim Group Following 4Q Results; 'Media Revenue Grows'
Mar 9, 2017 04:05PM ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Mar 9, 2017 08:02AM Maxim Group Downgrades Virtusa (VRTU) to Hold
Mar 8, 2017 09:21AM Gladstone Land (LAND) Prices 1.68M Offering of Common Stock at $11.35/Share
Mar 8, 2017 09:14AM Gladstone Land Corporation Announces Pricing of Common Stock Offering
Mar 8, 2017 08:14AM Maxim Group Maintains Buy Rating and $6 PT on Aeterna Zentaris (AEZS) on EMA Pediatric Committee Agreement for Macrilen
Mar 8, 2017 07:50AM Maxim Group Upgrades ManTech (MANT) to Buy
Mar 8, 2017 07:49AM Maxim Group Reiterates Buy Rating and $6 PT on BrainStorm Cell Therapeutics (BCLI) Following New CMO Appointment
Mar 7, 2017 04:20PM Gladstone Land (LAND) Plans 1.4M Common Stock Offering
Mar 7, 2017 04:16PM Gladstone Land Corporation Announces Common Stock Offering
Mar 7, 2017 09:22AM OncoSec to Present at Scientific and Investment Conferences in March
Mar 7, 2017 07:43AM Maxim Group Reiterates Buy Rating and $14 PT on Mesoblast (MESO) Following MSC-100IV Fast Track Designation
Mar 6, 2017 09:00AM New Age Beverages Corporation Launches Aspen Pure Probiotic, The World's First Shelf-Stable Probiotic Water
Mar 6, 2017 07:00AM CytoSorbents to Present at the Maxim Group - Haitong Securities Inaugural Healthcare Investor and Partnering Conference
Mar 3, 2017 07:44AM Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in Shanghai
Mar 2, 2017 09:00AM New Age Beverages Corporation Expands XingTea(R) Brand With Jumbo, the Largest Retailer in Chile
Feb 28, 2017 09:00AM New Age Beverages Corporation Launches Shelf Stable Bucha Live Kombucha, Expands in North America
Feb 28, 2017 07:30AM Viking Therapeutics to Present at Upcoming Investor Conferences
Feb 27, 2017 01:26PM Maxim Group Downgrades bluebird bio (BLUE) to Hold
Feb 27, 2017 08:18AM Arch Therapeutics to Provide Corporate Update at the Maxim Group - Haitong Securities Healthcare Investor and Partnering Conference
Feb 24, 2017 08:33AM Provectus Biopharmaceuticals Provides Information On Rights Offering Deadline
Feb 24, 2017 07:37AM Maxim Group Starts MYnd Analytics (MYAN) at Buy
Feb 23, 2017 04:49PM Maxim Group Starts Zynerba Pharmaceuticals (ZYNE) at Buy
Feb 23, 2017 09:43AM Rosetta Genomics Closes Second Tranche of Previously Announced Private Placement of Convertible Debentures
Feb 22, 2017 05:22PM Medley Management Inc. Announces Closing of Additional $34.5 Million Medley LLC Public Offering of 7.25% Notes Due 2024
Feb 21, 2017 04:06PM Auris Medical Announces Closing of $10 Million Public Offering
Feb 21, 2017 03:11PM Americans eat out less as higher menu prices take a bite from restaurant visits: Reuters/Ipsos poll
Feb 17, 2017 02:35PM New Age Beverages Corporation Announces Closing of Public Offering of Common Stock
Feb 17, 2017 02:29PM Maxim Group Reiterates Buy on Abeona Therapeutics (ABEO) Following ABO-102 Update
Feb 17, 2017 08:34AM Maxim Group Downgrades Orchid Island Capital (ORC) to Hold Citing Valuation
Feb 16, 2017 07:43PM Medley Management Inc. Announces Upsizing and Pricing of Additional $30 Million of Medley LLC 7.25% Notes Due 2024
Feb 16, 2017 09:36AM Medley Management Inc. Announces Re-Opening of Public Offering of Medley LLC Notes Due 2024
Feb 15, 2017 03:36PM Cytori Therapeutics, Inc. (CYTX) PT Raised to $10 at Maxim Group on Closure of the Azaya Deal
Feb 15, 2017 08:55AM COPsync Announces $1.1 Million Registered Direct Offering of Common Stock
Feb 15, 2017 08:31AM Auris Medical Holding (EARS) Prices 10M Shares and Warrants at $0.70/Share
View More Recent Stories View Older Stories